Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Valimenta™ Labs Releases University Clinical Study Bolstering Proprietary Liposomal Technology


News provided by

Valimenta Labs

Mar 01, 2016, 11:03 ET

Share this article

Share toX

Share this article

Share toX

FORT COLLINS, Colo., March 1, 2016 /PRNewswire/ -- There are many untested liposomal products on the market.  How do you know if the products you are taking are backed by science and facts or are simply marketing hype?  Here we offer a scientific study, performed in an academic setting, to illustrate our dedication to true liposome science.

Full report available at:  http://www.valimenta.com/science.html#oht:lang=en-us

Continue Reading
Figure 1 shows that, compared with "normal" Vitamin C ingestion (single dose of 4 g), ingestion of Liposomal Vitamin C (also 4 g) leads to appreciably greater circulating Vitamin C concentrations.  Figure 2.  Ingestion of liposomal Vitamin C quenches the oxidative stress (reactive oxygen species) during an ischemia-reperfusion study using a blood pressure cuff around the upper arm and inflated to very high pressures for 20-minutes.  Figure 3. Dynamic light scattering analysis of the liposomal diameter size of liposomal vitamin C.
Figure 1 shows that, compared with "normal" Vitamin C ingestion (single dose of 4 g), ingestion of Liposomal Vitamin C (also 4 g) leads to appreciably greater circulating Vitamin C concentrations. Figure 2. Ingestion of liposomal Vitamin C quenches the oxidative stress (reactive oxygen species) during an ischemia-reperfusion study using a blood pressure cuff around the upper arm and inflated to very high pressures for 20-minutes. Figure 3. Dynamic light scattering analysis of the liposomal diameter size of liposomal vitamin C.

What is a liposome?
Liposomes are tiny nano-sized bubbles with an outer shell comprised of healthy lipids and a hollow aqueous center that can be filled with a variety of substances, such as Vitamin C.  We have long postulated that the outer layer of the liposome protects the Vitamin C from gastric juices and liver enzymes; now, clinical studies are showing that liposomes support the absorption of nutrition, such as Vitamin C, and have excellent efficacy. 

PART 1:  How much Liposomal Vitamin C absorbs into a person's blood (bioavailability)?
While high doses of regular vitamin C powder or capsules will be rejected at high rates from your body, Liposomal Vitamin C is a fantastic alternative.

Starting in 2012, a team at the Department of Health and Exercise Science at Colorado State University (abstract at www.fasebj.org) has been comparing Vitamin C concentrations in the blood after swallowing a "normal" Vitamin C powder, and after ingestion of Liposomal Vitamin C, made using our formulation and technology, in order to understand Vitamin C bioavailability.  Figure 1 shows that, compared with "normal" Vitamin C ingestion (single dose of 4 g), ingestion of Liposomal Vitamin C (also 4 g) leads to appreciably greater circulating Vitamin C concentrations.  Hence, liposomes facilitate Vitamin C delivery to the blood.  Having structural analysis and some pictures is nice; however, our interest is in achieving the intended goal of improved bioavailability.

PART 2:  What will Vitamin C do once in the blood (efficacy)?
The next step in the study is to determine if the Vitamin C concentration is meaningful.  In this regard, an ischemia reperfusion study was performed.  Ischemia describes any tissue that has been deprived of blood and oxygen.  Reperfusion occurs when the blood and oxygen supply is returned.  Unfortunately, reperfusion can cause massive oxidative stress on your cardiovascular system, as the oxygen interacts with metabolites produced by the oxygen-deprived tissues.  Per the blue line in the Figure 2, oxidative stress was reduced even during the increased oxidative stress of reperfusion.  Figure 2 illustrates how the ingestion of liposomal Vitamin C quenches the oxidative stress (reactive oxygen species) during an ischemia-reperfusion study using a blood pressure cuff around the upper arm and inflated to very high pressures for 20 minutes.

Full report available at:  http://www.valimenta.com/science.html#oht:lang=en-us

PART 3:  What is the size of the liposomes using this technology?
Another step in our study is to characterize size ranges for our formulations.  We have been making Liposomal Vitamin C with a peak particle size of 85 nm (nanometers) and with 92% of the particles being between 60 and 172 nm (Figure 3).  This tight distribution is indicative of a reproducible and highly controlled manufacturing methodology that we invented.

About Valimenta™
Valimenta™ Labs manufactures custom liposomal vitamin and herbal supplements.  Our proprietary no pressure, no heat, no solvent technology was invented during our 15 years of research on lipid structures was released in 2010.  Valimenta's formulators and flavoring experts have extensive experience in dietary supplement manufacturing, specializing in liposomes, liquid herbals, and energy/nutrition drinks for athletes. Our mission is to create and nurture long-term partnerships with you, growing together as we give the world the highest quality health products on the market. Our commitment to quality and your satisfaction is absolute. We formulate and manufacture to exceed the highest industry standards by ensuring the liposomes are made from non-hydrogenated, non-GMO, sunflower lipids in our common allergen free facility.  We have ongoing research into liposomal curcumin, liposomal resveratrol, liposomal glutathione, liposomal vitamin c so stay tuned for more updates.

Emek Blair, PhD 
[email protected]
970-825-5173
www.Valimenta.com
Valimenta™ Labs

Full report available at:  http://www.valimenta.com/science.html#oht:lang=en-us

These statements have not been evaluated by the Food and Drug Administration.  The research materials described are not intended to diagnose, treat, cure, or prevent any disease nor are any specific claims being made.

Photo - http://photos.prnewswire.com/prnh/20160229/338889-INFO

SOURCE Valimenta Labs

Related Links

http://www.Valimenta.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.